Terra Sigillata

The Pump Handle’s Liz Borowski put up a nice post summarizing the key points of the >400-page Food and Drug Administration Amendments Act of 2007 (H.R. 3580).

Missing from the bill were any further restrictions on pharmaceutical direct-to-consumer (DTC) drug advertising – according to Liz, some drug safety advocates were calling for a complete ban on DTC ads.

Since the FDA began permitting DTC advertising in 1997, the purpose of the ads has been viewed as less about patient education for underdiagnosed diseases (the original pitch) and more about getting patients to request specific drugs from their physicians.

Precise numbers on the return-on-investment (ROI) of DTC advertising are hard to come by, but one conservative estimate in 2002 by Steven Findlay of the National Institute for Health Care Management (PDF here) is that the most heavily advertised drugs experience sales increases of 20-32%.

DTC advertising has been so successful that Pharma is not the only stakeholder in opposing any restriction on this practice. As reported by the WSJ Health Blog the advertising industry has a remarkably vested interest in the DTC business:

But media and advertising groups were sweating about regulators cutting back on what has become a dependable stream of revenue. In the U.S., drug makers represented the tenth-biggest advertising category in 2006, spending $5.3 billion, or 3.5% of the total $149.6 billion U.S. ad market.

Ed Silverman, Newark Star-Ledger reporter and author of the blog Pharmalot, has more.

I guess we’ll be seeing more of Abe Lincoln and the talking beaver.

Comments

  1. #1 医疗健康搜索
    January 22, 2008

    Personal view is that direct-to-consumer advertising of drugs there is anything wrong. On the contrary, it can popularize the health knowledge of consumers, the consumer a better understanding of commonly used drugs, and also the consumer has the right to know.

  2. #2 keith, rn
    July 1, 2010

    re: 医疗健康搜索’s comment- as someone well versed in the machinations of the Industrialized Medical complex. DTC serves ONLY the Pharmaceutical Industry in that (1)it preys on the shortfalls inherent in a Managed Care environment; lack of time for teaching patients being the first. Following this, (2)Patient satisfaction has become more important than appropriate care. This speaks to numbers equals revenue. If a pt. comes into an office wanting something and they do not get it, they are not satisfied. see #1. Practitioners being poorly prepared for professional interpersonal relationships(read: poor bedside manner). Consumers are less interested in ‘knowing’ than they are in getting a ‘cure’ for what they believe ails them.